Characteristics and cardiovascular disease event rates among African Americans and whites who meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) trial inclusion criteria

PURPOSE: Determine the risk for cardiovascular disease (CVD) events among adults with clinically evident CVD who meet the inclusion criteria for the FOURIER clinical trial on PCSK9 inhibition in a real-world database. METHODS: We analyzed data from 2,072 African-American and 2,972 white REasons for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cardiovasc Drugs Ther
Main Authors: Colantonio, Lisandro D., Monda, Keri L., Rosenson, Robert S., Brown, Todd M., Mues, Katherine E., Howard, George, Safford, Monika M., Yedigarova, Larisa, Farkouh, Michael E., Muntner, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917479/
https://ncbi.nlm.nih.gov/pubmed/30746585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10557-019-06864-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados